Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| keratinocyte | 3 studies | 60% ± 22% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| skin | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 99% | 50.19 | 179 / 180 | 0% | 0 | 0 / 430 |
| uterus | 98% | 42.08 | 166 / 170 | 0% | 0 | 0 / 459 |
| brain | 98% | 50.10 | 2578 / 2642 | 0% | 0 | 0 / 705 |
| thymus | 94% | 32.91 | 616 / 653 | 0% | 0 | 0 / 605 |
| blood vessel | 91% | 31.97 | 1219 / 1335 | 0% | 0 | 0 / 0 |
| skin | 91% | 2283.48 | 1644 / 1809 | 0% | 0 | 0 / 472 |
| prostate | 88% | 28.19 | 215 / 245 | 0% | 0 | 0 / 502 |
| breast | 86% | 27.93 | 397 / 459 | 0% | 0 | 0 / 1118 |
| bladder | 81% | 25.10 | 17 / 21 | 0% | 0 | 0 / 504 |
| intestine | 79% | 23.98 | 763 / 966 | 0% | 0 | 0 / 527 |
| esophagus | 79% | 22.83 | 1136 / 1445 | 0% | 0 | 0 / 183 |
| adipose | 75% | 24.49 | 908 / 1204 | 0% | 0 | 0 / 0 |
| lung | 65% | 15.99 | 376 / 578 | 0% | 0 | 0 / 1155 |
| heart | 58% | 13.78 | 496 / 861 | 0% | 0 | 0 / 0 |
| kidney | 55% | 12.40 | 49 / 89 | 0% | 0 | 0 / 901 |
| muscle | 50% | 11.16 | 405 / 803 | 0% | 0 | 0 / 0 |
| liver | 40% | 8.62 | 90 / 226 | 0% | 0 | 0 / 406 |
| stomach | 37% | 9.90 | 132 / 359 | 0% | 0 | 0 / 286 |
| spleen | 35% | 6.93 | 85 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 19% | 3.41 | 50 / 258 | 0% | 0 | 0 / 230 |
| pancreas | 11% | 2.24 | 37 / 328 | 0% | 0 | 0 / 178 |
| peripheral blood | 4% | 0.73 | 40 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006955 | Biological process | immune response |
| GO_0006935 | Biological process | chemotaxis |
| GO_0060326 | Biological process | cell chemotaxis |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031728 | Molecular function | CCR3 chemokine receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008009 | Molecular function | chemokine activity |
| Gene name | CCL27 |
| Protein name | Chemokine (C-C motif) ligand 27 C-C motif chemokine 27 (CC chemokine ILC) (Cutaneous T-cell-attracting chemokine) (CTACK) (ESkine) (IL-11 R-alpha-locus chemokine) (Skinkine) (Small-inducible cytokine A27) CCL27 protein |
| Synonyms | CTAK PESKY hCG_20477 CTACK ILC ESKINE ALP SCYA27 |
| Description | FUNCTION: Chemotactic factor that attracts skin-associated memory T-lymphocytes. May play a role in mediating homing of lymphocytes to cutaneous sites. Binds to CCR10. |
| Accessions | B2RWM4 Q5VZ77 Q9Y4X3 ENST00000259631.5 |